Intelligence · Clinical Development
Pipeline search results
Programs matching “alzheimer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 141 pipeline programs matching "alzheimer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
LECANEMAB
Eisai Co.,
Early Preclinical Alzheimer’s Disease and Intermediate Amyloid, Preclinical Alzheimer’s Disease and Elevated Amyloid
1 trial -
Lecanemab
Eisai Co.,
Mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease dementia.
1 trial -
Levetiracetam NORMON comprimidos recubiertos...
The George Institute
Down syndrome, Alzheimer's Disease
1 trial -
NN6535-4725
NovoThirteen
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type
1 trial -
NN6535-4730
NovoThirteen
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type
1 trial -
NN6535-7519
NovoThirteen
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type
1 trial -
Nabilone
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
Pioglitazone
Takeda
Mild Cognitive Impairment Due to Alzheimer's Disease
2 trials -
Remternetug, Placebo to match LY
Eli Lilly Co.
Alzheimer’s Disease
1 trial -
Rosiglitazone Extended Release 2mg
GlaxoSmithKline
Alzheimer's Disease
1 trial -
VP4896
Voyager Therapeutics
Alzheimer's Disease
1 trial -
WN45443
Hoffmann-La Roche
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD)
1 trial -
WN45447
Hoffmann-La Roche
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)
1 trial -
bapineuzumab
Pfizer
Alzheimer Disease
1 trial -
18F-92
The First People's Hospital of Lianyungang
Alzheimer's Disease
1 trial -
219867
GlaxoSmithKline
Alzheimer's Disease
1 trial -
223646
GlaxoSmithKline
Alzheimer's Disease
1 trial -
5-(1-(2-[18F] fluoroethoxy))-[3-(6 for Alzheimers Disease, sporadic Ce…
Disc Medicine
Alzheimers Disease, sporadic Cerebral Amyloid Angiopathy, Parkinson
1 trial -
64042056ALZ2001
Janssen-Cilag International N.V.
Preclinical Alzheimer’s Disease
1 trial -
ABBV-552
AbbVie
Alzheimer's Disease (AD)
1 trial -
ACU193-201
Acumen Pharmaceuticals
Early Alzheimer’s Disease (Mild Cognitive Impairment and Mild Dementia Due to Alzheimer’s Disease)
1 trial -
AH0003
Lacuna Pharma Pty Ltd
Alzheimer’s Disease
1 trial -
AMX0035
Amylyx Pharmaceuticals EMEA B.V.
Alzheimer Disease
1 trial -
ARO-MAPT-SC
Arrowhead Pharmaceuticals Ireland Limited
Alzheimer Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.